► Episode 3 Understanding the Timing of Therapy in CLL
The optimal length of time to wait to initiate treatment for patients with chronic lymphocytic leukemia (CLL), as well as the length of time to remain on treatment, are described by Nicole Lamanna, M.D.
Danise Hoover, a patient with chronic lymphocytic leukemia, recalls her experience with first-line chemoimmunotherapy. Expert Nicole Lamanna, M.D., provides an overview of regimens typically used in patients such as Danise.
► Episode 13 Considering a Clinical Trial for CLL Treatment
Patient and clinician insight on the process involved in the enrollment in a clinical trial for the treatment of chronic lymphocytic leukemia and typical patient factors that help determine one’s eligibility.
► Episode 14 Danise: Experience With Venetoclax Targeted Therapy
Danise Hoover recalls her experience receiving venetoclax, an oral targeted agent. Nicole Lamanna, M.D., discusses the rationale for Danise’s treatment recommendation and remarks on the benefits of treating patients with chronic lymphocytic leukemia with venetoclax.